Concepedia

Patrik Bondarov

PB

Statistics

Publications

6

Citations

189

H-Index

6

Active since

2004

Affiliations

AstraZeneca (Sweden)(Current)

The University of Adelaide

Women's and Children's Hospital

Patrik Bondarov is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

2004–2015

6

Publications

6

Pharmacokinetics and Acid‐suppressive Effects of Esomeprazole in Infants 1–24 Months Old With Symptoms of Gastroesophageal Reflux Disease

Taher Omari, Geoffrey P. Davidson, Patrik Bondarov et al. · Journal of Pediatric Gastroenterology and Nutrition · 2007 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacodynamics and Systemic Exposure of Esomeprazole in Preterm Infants and Term Neonates with Gastroesophageal Reflux Disease

Taher Omari, Per Lundborg, Marie Sandström et al. · The Journal of Pediatrics · 2009 · 52 citations

Medicine, Pediatrics, Pharmacology +17

Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study

Clive H. Wilder‐Smith, Kerstin Röhss, Patrik Bondarov et al. · Alimentary Pharmacology & Therapeutics · 2004 · 29 citations

Medicine, Pharmacology, Pharmacotherapy +14

Intravenous esomeprazole (40???mg and 20???mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies

Clive H. Wilder‐Smith, Patrik Bondarov, Marie Lundgren et al. · European Journal of Gastroenterology & Hepatology · 2005 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +10

Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously

A Rónaszéki, Marco Alings, Kenneth Egstrup et al. · EP Europace · 2011 · 12 citations · Full text

Medicine, Cardiology, Pharmacology +15

1–5 of 6